SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-047684
Filing Date
2022-08-15
Accepted
2022-08-15 07:31:09
Documents
56
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_gamidacell.htm   iXBRL 10-Q 1285167
2 CERTIFICATION f10q0622ex31-1_gamidacell.htm EX-31.1 9700
3 CERTIFICATION f10q0622ex31-2_gamidacell.htm EX-31.2 9619
4 CERTIFICATION f10q0622ex32-1_gamidacell.htm EX-32.1 3649
5 CERTIFICATION f10q0622ex32-2_gamidacell.htm EX-32.2 3623
  Complete submission text file 0001213900-22-047684.txt   4132814

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE gmda-20220630.xsd EX-101.SCH 47362
7 XBRL CALCULATION FILE gmda-20220630_cal.xml EX-101.CAL 24088
8 XBRL DEFINITION FILE gmda-20220630_def.xml EX-101.DEF 157968
9 XBRL LABEL FILE gmda-20220630_lab.xml EX-101.LAB 385431
10 XBRL PRESENTATION FILE gmda-20220630_pre.xml EX-101.PRE 171069
50 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_gamidacell_htm.xml XML 321848
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38716 | Film No.: 221162336
SIC: 2836 Biological Products, (No Diagnostic Substances)